Primary non-syndromic lymphoedema (Meige disease) is not caused by mutations in FOXC2

European Journal of Human Genetics

Volumn 16, Issue 3, 2008, Pages 300-304

  Rezaie, Tayebeh ^a   Ghoroghchian, Rose ^a   Bell, Rachel ^b   Brice, Glen ^b   Hasan, Ali ^b   Burnand, Kevin ^c   Vernon, Steve ^d   Mansour, Sahar ^b   Mortimer, Peter ^b   Jeffery, Steve ^b   Child, Anne ^b   Sarfarazi, Mansoor ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXC2;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FRAMESHIFT MUTATION; GENE CLUSTER; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC SCREENING; HUMAN; LYMPHEDEMA; MALE; MEIBOMIAN GLAND; MEIGE DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONFORMATION; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MEIGE SYNDROME; MUTATION;

MEIBOMIA;

EID: 39749157145     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201982     Document Type: Article

References (17)

1. Brice G, Mansour S, Bell R et al: Analysis of the phenotypic abnormalities in lymphoedema -distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 2002; 39: 478-483.
2. Mellor P., Brice G, Stanton A et al: Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007; 115: 1912-1920.
3. Evans AL, Brice G, Sotirova V et al: Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 1999; 64: 547-555.
4. Ferrell RE, Levinson KL, Esman JH et al: Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet 1998; 7: 2073-2078.
5. Mangion J, Rahman N, Mansour S et al: A gene for lymphedema- distichiasis maps to 16q24.3. Am J Hum Genet 1999; 65: 427-432.
6. Bell R, Brice G, Child AH et al: Analysis of lymphoedema- distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum Genet 2001; 108: 546-551.
7. Erickson RP, Dagenais SL, Caulder MS et al: Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations. J Med Genet 2001; 38: 761-766.
8. Fang J, Dagenais SL, Erickson RP et al: Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000; 67: 1382-1388.
9. Finegold DN, Kimak MA, Lawrence EC et al: Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 2001; 10: 1185-1189.
10. Traboulsi EI, Al-Khayer K, Matsumoto M et al: Lymphedema- distichiasis syndrome and FOXC2 gene mutation. Am J Ophthalmol 2002; 134: 592-596.
11. Sholto-Douglas-Vernon C, Bell R, Brice G et al: Lymphoedema- distichiasis and FOXC2: Unreported mutations, de navo mutation estimate, families without coding mutations. Hum Genet 2005; 117: 238-242.
12. Bahuau M, Houdayer C, Tredano M, Soupre V, Couderc R, Vazquez MP: FOXC2 truncating mutation in distichiasis, lymphedema, and cleft palate. Clin Genet 2002; 62: 470-473.
13. Brooks BP, Dagenais SL, Nelson CC et al: Mutation of the FOXC2 gene in familial distichiasis. J Aapos 2003; 7: 354-357.
14. Kaufmann E, Knochel W: Five years on the wings of fork head. Mech Dev 1996; 57: 3-20.
15. Falls HF, Kertesz ED: A new syndrome combining Pterygium colli with developmental anomalies of the eyelids and lymphatics of the lower extremities. Trans AM Ophthalmol Soc 1964; 62: 248-275.
16. Bloom D: Hereditary lymphedema (Nonne-Milroy-Meige). Report of a famly with hereditary lymphedema associated with ptosis of the eyelids in several generations. N Y J Med 1941; 41: 856-863.
17. Hoque SR, MansouN S, Mortimer PS: Yellow nail syndrome: not a genetic disorder?. Eleven new cases and a review of the literature. Br J Dermatol 2007; 156: 1230-1234.